Extracellular vesicles as novel assay tools to study cellular interactions of anti-infective compounds - A perspective.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Issue Date
2021-04-20
Metadata
Show full item recordAbstract
Sudden outbreaks of novel infectious diseases and the persistent evolution of antimicrobial resistant pathogens make it necessary to develop specific tools to quickly understand pathogen-cell interactions and to study appropriate drug delivery strategies. Extracellular vesicles (EVs) are cell-specific biogenic transport systems, which are gaining more and more popularity as either diagnostic markers or drug delivery systems. Apart from that, there are emerging possibilities for EVs as tools to study drug penetration, drug-membrane interactions as well as pathogen-membrane interactions. However, it appears that the potential of EVs for such applications has not been fully exploited yet. Considering the vast variety of cells that can be involved in an infection, vesicle-based analytical methods are just emerging and the number of reported applications is still relatively small. Aim of this review is to discuss the current state of the art of EV-based assays, especially in the context of antimicrobial research and therapy, and to present some new perspectives for a more exhaustive and creative exploration in the future.Citation
Adv Drug Deliv Rev. 2021 Jun;173:492-503. doi: 10.1016/j.addr.2021.04.010. Epub 2021 Apr 20.Affiliation
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.Publisher
ElsevierJournal
Advanced drug delivery reviewsPubMed ID
33857554Type
ReviewLanguage
enEISSN
1872-8294ae974a485f413a2113503eed53cd6c53
10.1016/j.addr.2021.04.010
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
- Authors: Sil S, Dagur RS, Liao K, Peeples ES, Hu G, Periyasamy P, Buch S
- Issue date: 2020 Sep
- Exploring interactions between extracellular vesicles and cells for innovative drug delivery system design.
- Authors: Kooijmans SAA, de Jong OG, Schiffelers RM
- Issue date: 2021 Jun
- Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
- Authors: Shahjin F, Chand S, Yelamanchili SV
- Issue date: 2020 Sep
- Engineered extracellular vesicles and their mimetics for clinical translation.
- Authors: Kim H, Kim D, Nam H, Moon S, Kwon YJ, Lee JB
- Issue date: 2020 May 1
- Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
- Authors: Meng W, He C, Hao Y, Wang L, Li L, Zhu G
- Issue date: 2020 Dec